Zobrazeno 1 - 10 of 150 pro vyhledávání: '"Mitsuhiro, Uchiba"'
1
Akademický článek
Partial Splenic Embolization in a Patient with Hemophilia A and Severe Thrombocytopenia: A Case Report
Autor: Tomofumi Nakamura, Mitsuhiro Uchiba, Hirotomo Nakata, Takao Mizumoto, Toru Beppu, Shuzo Matsushita
Publikováno v: Hematology Reports, Vol 16, Iss 2, Pp 185-192 (2024)
We report a patient with hemophilia A who underwent partial splenic embolization (PSE) for severe thrombocytopenia secondary to portal hypertension-induced splenomegaly, resulting in a stable long-term quality of life. The patient was diagnosed with
Externí odkaz: https://doaj.org/article/7a5f8a4f02904a2ea6a562771b9f6726
Zobrazit plný text záznamu
2
Akademický článek
Using weighted harmonic mean for prediction of APTT in the mixing test
Autor: Mitsuhiro Uchiba, Masao Matsuoka
Publikováno v: Thrombosis Update, Vol 8, Iss , Pp 100114- (2022)
Background: The mixing test of activated partial thromboplastin time (APTT) is used for differentiating factor deficiency (FD), lupus anticoagulant (LAC), and acquired hemophilia A (AHA). However, the interpretation of the mixing test is not fully st
Externí odkaz: https://doaj.org/article/aa8693cd15f54ee2aeed97401e6c78f1
Zobrazit plný text záznamu
4
Glycosylated ferritin as an improved marker for post-transfusion iron overload
Autor: Katsuyoshi Ikeda, Yoko Fukuyoshi, Toshiro Yokoyama, Hirotaka Matsui, Mitsuhiro Uchiba, Yuji Yonemura, Tsuyuko Yamauchi, Ayako Ishihara
Publikováno v: International Journal of Hematology. 113:537-546
Red blood cell (RBC) transfusion is an effective therapy for anemia, but repeated transfusions may cause iron overload-related damage to various organs. Iron chelation therapy, now widely available for patients who have received transfusions, is expe
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5154e5f2dd7d91bd6377c981074f4a7d
https://doi.org/10.1007/s12185-020-03056-9
Zobrazit plný text záznamu
8
Perioperative safety and haematostatic efficacy of a new bypassing agent pd-FVIIa/FX (Byclot) in haemophilia patients with high-responding type inhibitors
Autor: Rie Shirayama, Harumi Kakuda, Masataka Ishimura, Yoshiyasu Ogata, Yushi Chikasawa, Hideyuki Takedani, Akira Shirahata, Akira Ishiguro, Kiyotaka Isobe, Mitsuhiro Uchiba, Koichi Kusuhara
Publikováno v: Blood coagulationfibrinolysis : an international journal in haemostasis and thrombosis. 30(8)
The novel agent pd-FVIIa/FX is a 1 : 10 protein weight mixture of activated factor VII (FVIIa) and factor X (FX) derived from donated blood plasma. A phase III clinical trial of pd-FVIIa/FX revealed high efficacy for bleeding episodes in haemophilia
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38931c45e58bf51ba258e102ec54428a
https://pubmed.ncbi.nlm.nih.gov/31738288
Zobrazit plný text záznamu
9
[Spontaneous remission of acquired factor XIII inhibitor concurrent to development of IgA-λ type multiple myeloma]
Autor: Shikiko, Ueno, Junko, Nozaki, Shinichi, Kusano, Yawara, Kawano, Yoshitaka, Kikukawa, Yutaka, Okuno, Hiroyuki, Hata, Masao, Matsuoka, Mitsuhiro, Uchiba
Publikováno v: [Rinsho ketsueki] The Japanese journal of clinical hematology. 60(10)
Coagulation factor XIII is a fibrin-stabilizing factor that leads to the crosslinking of fibrin when activated by thrombin. Acquired factor XIII inhibitor is caused when antibodies are generated against factor XIII, reducing its activity. Here we rep
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::faa6c711a07fe2c53761cda75c6b9ee4
https://pubmed.ncbi.nlm.nih.gov/31695005
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje